Shanghai Yizhong Pharmaceutical Co., Ltd.

SHSE:688091 Stock Report

Market Cap: CN¥8.2b

Shanghai Yizhong Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jingsong Zhou

Chief executive officer

CN¥1.5m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership19.6%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Subdued Growth No Barrier To Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) With Shares Advancing 27%

Nov 20
Subdued Growth No Barrier To Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) With Shares Advancing 27%

We Think You Can Look Beyond Shanghai Yizhong Pharmaceutical's (SHSE:688091) Lackluster Earnings

Nov 08
We Think You Can Look Beyond Shanghai Yizhong Pharmaceutical's (SHSE:688091) Lackluster Earnings

There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump

Oct 01
There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump

Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?

Aug 20
Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?

What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You

Jul 24
What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You

Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance

Apr 15
Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance

Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely

Mar 29
Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely

CEO

Jingsong Zhou (56 yo)

no data

Tenure

CN¥1,481,200

Compensation

Mr. Zhou Jingsong serves as Chairman of the Board and General Manager at Shanghai Yizhong Pharmaceutical Co., Ltd.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 13:21
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Yizhong Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution